3 studies found for:    16790701 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge
Condition: Cat Allergy
Interventions: Drug: Omalizumab;   Drug: Placebo
2 Completed The Effect of Omalizumab on Responses to Cat Allergen Challenge
Condition: Allergic Rhinitis
Interventions: Drug: omalizumab;   Drug: placebo
3 Withdrawn Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
Conditions: Asthma;   Airway Inflammation;   Airflow Obstruction;   Airway Hyperactivity
Intervention: Drug: Pioglitazone Hydrochloride

Indicates status has not been verified in more than two years